SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
extension of the US R&D tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN TAYLOR | — |
Health Issues HCR
Issues related to a regulatory pathway and Medicare reimbursement for follow on biologics; Comparative effectiveness; General information related to Health Information Technology; issues related to Deep Vein Thrombosis (DVT) awareness and quality of care; and coverage and payment issues related to health care reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| EDWARD GREISSING | — |
Pharmacy PHA
issues related to the final regulations implementing those provisions of HR4896 "National Defense Authorization Act for FY2008" related to TRICARE retail pharmacy sales.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD M HODGE | — |
Medicare/Medicaid MMM
Medicare Part D Annual Call Letter, issues related to formulary specialty tiers and coverage of prescription drugs; reporting measures under Medicare Part A related to hospital acquired conditions; and anticoagulation reimbursement under Medicare Part B
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK COIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.